hepatoblastoma

  • n.肝母细胞瘤
hepatoblastomahepatoblastoma
  1. Objective To investigate clinical features and treatment of children with hepatoblastoma .

    目的探讨小儿肝母细胞瘤的临床特点和诊治方法。

  2. Objective To investigate the diagnosis and treatment of hepatoblastoma in children .

    目的探讨儿童肝母细胞瘤的临床诊断与治疗方案。

  3. CT findings and its clinical application in hepatoblastoma of children

    小儿肝母细胞瘤的CT表现及临床应用价值

  4. Study of Bcl-2 and P53 Gene Expression on Hepatoblastoma and its Significance

    Bcl-2、P53基因在肝母细胞瘤中的表达研究及意义

  5. The Study of the Correlation of DNA Content with PCNA Expression in Hepatoblastoma

    肝母细胞瘤细胞核DNA含量与增殖细胞核抗原表达的相关性研究

  6. Induction of human hepatoblastoma cell line cells ' differentiation by interleukin-4

    白细胞介素4诱导人肝母细胞瘤系细胞分化的实验研究

  7. Conclusion The clinical feature of hepatoblastoma was that the tumor grew rapidly .

    结论肿瘤迅速生长是肝母细胞瘤的临床特征。

  8. CT and clinic determination of pediatric hepatoblastoma and hepatic cell carcinoma

    小儿肝母细胞瘤与肝细胞癌的CT及临床鉴别

  9. The effects of human IL-4 gene transfer on differentiation and apoptosis in hepatoblastoma cells

    人IL-4基因修饰诱导肝母细胞瘤细胞凋亡及分化的研究

  10. Significance of the expression of vascular endothelial cell growth factor C and its receptor in hepatoblastoma

    用蛋白印迹技术初步评价肝母细胞瘤血管内皮生长因子表达的意义

  11. Expression of Hypoxia-inducible Factors and Its Related Proteins in Hepatoblastoma

    缺氧诱导因子及其相关蛋白在肝母细胞瘤中的表达

  12. Conclusion Radical resection of tumor plays a key role in the treatment of hepatoblastoma in children .

    结论肿瘤完整切除是儿童肝母细胞瘤治疗的关键;

  13. Appraisal of preoperative interventional therapy in the treatment of hepatoblastoma in infants

    术前介入在肝母细胞瘤治疗中的应用评价

  14. Treatment and outcome of 14 children with hepatoblastoma

    14例儿童肝母细胞瘤综合治疗的疗效观察

  15. Detection of apoptosis in pre and post chemotherapeutic tissue of hepatoblastoma and its clinical significance

    肝母细胞瘤化疗前后细胞凋亡检测及其临床意义

  16. Conclusion Early discovering , diagnosis and treatment of hepatoblastoma are very important to improve its curative resection rate .

    结论肝母细胞瘤早发现、早诊断、早治疗对提高手术根治性切除率有十分重要的意义;

  17. Conclusion : The VX2 liver tumor is similar to the hepatoblastoma of human beings .

    结论:兔VX2肝肿瘤类似人类肝母细胞瘤。

  18. Results : The positive rates of P53 expression on hepatoblastoma was 69.2 % ( P < 0.01 ) .

    结果:P53在肝母细胞瘤中表达阳性率为69.2%(P<0.01),P53的阳性表达水平,临床分期越晚越高(P<0.05)。

  19. Objective To summarize and evaluate the experience of living-related party liver transplantation for hepatoblastoma in children .

    目的探讨小儿部分亲体肝移植治疗肝母细胞瘤的临床经验。

  20. Determination of serum AFP in infants with hepatoblastoma and yolk-sac tumors

    小儿肝母细胞瘤和卵黄囊瘤血清AFP测定

  21. Methods The clinicopathological data from 24 cases with hepatoblastoma were analysed , and immunohistochemical study was performed in 18 cases .

    方法对24例小儿肝细胞瘤进行临床病理分析和组织学分型,其中18例作7种标记的免疫组化研究;对手术病例进行随访观察。

  22. Conclusion of intervention , radical resection and chemotherapy is the reliable and effective therapy for children with hepatoblastoma .

    介入治疗、根治性肿瘤切除配合化疗是小儿肝母细胞瘤可靠而有效的治疗方法。

  23. Methods The clinical records of4 hospitalized children diagnosed with hepatoblastoma were retrospectively analyzed and followed-up .

    方法对诊治的4例小儿肝母细胞瘤的临床资料进行回顾性分析和随访。

  24. IL-4 gene transfer induces the differentiation of cells and inhibits the activity of telomerase in hepatoblastoma cells

    IL-4基因转染诱导肝母细胞瘤分化及抑制端粒酶活性

  25. AFP was an important marker of hepatoblastoma .

    AFP是肝母细胞瘤的重要标志物。

  26. Objective To investigate the diagnosis experience , effects of Surgical treatment and prognosis of hepatoblastoma ( HB ) in childhood .

    目的总结小儿肝母细胞瘤诊治经验,探讨影响预后因素。

  27. Objective To investigate the relationship between immunoreaction of histologic subtype and prognosis in hepatoblastoma of children .

    目的探讨肝母细胞瘤各组织类型的免疫表达和预后的关系。

  28. Transcatheter arterial chemoembolization and delayed surgery for infant hepatoblastoma

    婴儿肝母细胞瘤的介入治疗及延迟手术治疗

  29. This article reviewed progresses in combined therapy of hepatoblastoma : surgery , methods to add the opportunity to surgery and drug treatment .

    现从外科手术治疗、增加手术切除机会的手段、药物治疗三方面将近年来的治疗进展做一综述。

  30. Results : AFP was significantly increased in 85 % patients with hepatoblastoma and 93 % patients with yolk-sac tumors .

    结果:肝母细胞瘤和卵黄囊瘤术前血清AFP阳性率分别为85%,93%。